<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00489606</url>
  </required_header>
  <id_info>
    <org_study_id>SK3530_DI_TS</org_study_id>
    <nct_id>NCT00489606</nct_id>
  </id_info>
  <brief_title>Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530</brief_title>
  <official_title>Clinical Trial to Investigate the Influence of Drug Interaction After Oral Administration of Tamsulosin and SK3530 in Healthy Male Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SK Chemicals Co.,Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SK Chemicals Co.,Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the pharamcodynamic effects of coadministrated SK3530(PDE5 inhibitor) and
      tamsulosin, phase I study in healthy volunteers was designed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During each of the two periods of a randomized, double-blind, placebo-controlled, crossover
      study, 16 healthy men received tamsulosin 0.2 mg daily for 7 days and either a single 100 mg
      of SK3530 or placebo on day7. The blood pressure and heart rate were monitored before and for
      24 hours after SK3530 or placebo.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">June 2007</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal decrease from baseline in supine SBP</measure>
    <time_frame>within 6 hrs after SK3530 or placebo</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximal decrease from baseline in standing SBP, supine/standing DBP &amp; HR</measure>
    <time_frame>within 6 hrs after SK3530 or placebo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outlier analysis: i) Standing/supine SBP &lt; 85 mmHg, DBP &lt; 45 mmHg; ii) Change in standing/supine SBP &gt; 30 mmHg, DBP &gt; 20 mmHg</measure>
    <time_frame>within 6 hrs after SK3530 or placebo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postural hypotension</measure>
    <time_frame>within 6 hrs after SK3530 or placebo</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">16</enrollment>
  <condition>Erectile Dysfunction</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SK3530</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ages 20 to 50

          -  body weight of IBMÂ±20%

        Exclusion Criteria:

          -  cardiovascular disease

          -  color-blindness or weakness

          -  hypotension, hypertension, orthostatic hypertension

          -  abmormal QTc (&gt;430 ms)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>In-Jin Chang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2007</study_first_submitted>
  <study_first_submitted_qc>June 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2007</study_first_posted>
  <last_update_submitted>June 20, 2007</last_update_submitted>
  <last_update_submitted_qc>June 20, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 21, 2007</last_update_posted>
  <keyword>SK3530</keyword>
  <keyword>tamsulosin</keyword>
  <keyword>hemodynamic interaction</keyword>
  <keyword>safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tamsulosin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

